- Type / Class
- Equity / Common Stock
- Shares outstanding
- 82,201,196
- Total 13F shares
- 69,898,687
- Share change
- +742,877
- Total reported value
- $995,227,037
- Put/Call ratio
- 88%
- Price per share
- $14.24
- Number of holders
- 148
- Value change
- +$20,107,476
- Number of buys
- 68
- Number of sells
- 63
Quarterly Holders Quick Answers
What is CUSIP 30233G209?
CUSIP 30233G209 identifies EYPT - EyePoint, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 30233G209:
Top shareholders of EYPT - EyePoint, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| EW Healthcare Partners, L.P. |
3/4/5
|
Other*, 10%+ Owner |
—
class O/S missing
|
3,490,921
|
$87,327,483 | — | 01 Sep 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
10%
|
8,325,000
|
$78,338,250 | — | 30 Jun 2025 | |
| SUVRETTA CAPITAL MANAGEMENT, LLC |
13F
|
Company |
8.3%
|
6,804,091
|
$64,026,496 | — | 30 Jun 2025 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
8.3%
|
6,800,000
|
$63,988,000 | — | 30 Jun 2025 | |
| BlackRock, Inc. |
13D/G
13F
|
Company |
6.5%
|
4,485,402
|
$63,872,124 | $0 | 30 Sep 2025 | |
| FEDERATED HERMES, INC. |
13D/G
13F
|
Company |
6.7%
|
4,599,450
|
$43,281,744 | $0 | 30 Jun 2025 | |
| FRANKLIN RESOURCES INC |
13F
13D/G
|
Company |
6.1%
from 13D/G
|
4,301,123
|
$40,473,570 | — | 30 Jun 2025 | |
| VANGUARD GROUP INC |
13F
|
Company |
4.6%
|
3,802,646
|
$35,782,900 | — | 30 Jun 2025 | |
| TCG Crossover Management, LLC |
13F
|
Company |
4.3%
|
3,572,335
|
$33,615,672 | — | 30 Jun 2025 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
2.9%
|
2,344,210
|
$22,059,016 | — | 30 Jun 2025 | |
| RA CAPITAL MANAGEMENT, L.P. |
13D/G
|
— |
4.7%
|
3,181,818
|
$20,809,090 | $0 | 31 Dec 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.9%
|
1,592,048
|
$14,984,449 | — | 30 Jun 2025 | |
| STATE STREET CORP |
13F
|
Company |
1.8%
|
1,515,549
|
$14,261,316 | — | 30 Jun 2025 | |
| Patient Square Capital LP |
13F
|
Company |
1.6%
|
1,352,837
|
$12,730,196 | — | 30 Jun 2025 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.6%
|
1,280,692
|
$12,051,312 | — | 30 Jun 2025 | |
| Essex Woodlands Management, Inc. |
13F
|
Company |
1.4%
|
1,169,857
|
$11,008,354 | — | 30 Jun 2025 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.3%
|
1,050,000
|
$9,880,500 | — | 30 Jun 2025 | |
| Aberdeen Group plc |
13F
|
Company |
1.3%
|
1,031,201
|
$9,703,601 | — | 30 Jun 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.99%
|
814,153
|
$7,661,184 | — | 30 Jun 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.95%
|
782,642
|
$7,364,661 | — | 30 Jun 2025 | |
| HSBC HOLDINGS PLC |
13F
|
Company |
0.77%
|
631,074
|
$5,944,652 | — | 30 Jun 2025 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.72%
|
593,091
|
$5,580,986 | — | 30 Jun 2025 | |
| Blue Owl Capital Holdings LP |
13F
|
Company |
0.68%
|
562,594
|
$5,294,010 | — | 30 Jun 2025 | |
| Principia Wealth Advisory, LLC |
13F
|
Company |
0.65%
|
533,778
|
$5,022,851 | — | 30 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.63%
|
515,613
|
$4,851,918 | — | 30 Jun 2025 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.62%
|
512,113
|
$4,818,984 | — | 30 Jun 2025 | |
| Woodline Partners LP |
13F
|
Company |
0.61%
|
500,335
|
$4,708,152 | — | 30 Jun 2025 | |
| FMR LLC |
13F
|
Company |
0.54%
|
446,305
|
$4,199,732 | — | 30 Jun 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.46%
|
376,776
|
$3,545,462 | — | 30 Jun 2025 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.43%
|
351,348
|
$3,306,185 | — | 30 Jun 2025 | |
| Granahan Investment Management, LLC |
13F
|
Company |
0.41%
|
340,984
|
$3,208,659 | — | 30 Jun 2025 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.4%
|
329,254
|
$3,098,280 | — | 30 Jun 2025 | |
| Artia Global Partners LP |
13F
|
Company |
0.39%
|
316,700
|
$2,980,147 | — | 30 Jun 2025 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.38%
|
313,979
|
$2,954,542 | — | 30 Jun 2025 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.34%
|
281,115
|
$2,645,292 | — | 30 Jun 2025 | |
| Therapeutics Ocumension |
3/4/5
|
Director |
—
class O/S missing
|
100,221
|
$2,507,088 | — | 11 Jan 2024 | |
| Ye Liu |
3/4/5
|
Director |
—
class O/S missing
|
100,221
|
$2,507,088 | — | 11 Jan 2024 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.32%
|
265,109
|
$2,494,676 | — | 30 Jun 2025 | |
| AXA S.A. |
13F
|
Company |
0.32%
|
263,233
|
$2,477,023 | — | 30 Jun 2025 | |
| Bleichroeder LP |
13F
|
Company |
0.31%
|
256,515
|
$2,413,806 | — | 30 Jun 2025 | |
| MYDA Advisors LLC |
13F
|
Company |
0.3%
|
250,000
|
$2,352,500 | — | 30 Jun 2025 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.3%
|
247,412
|
$2,328,147 | — | 30 Jun 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.27%
|
225,964
|
$2,126,000 | — | 30 Jun 2025 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.25%
|
207,702
|
$1,954,474 | — | 30 Jun 2025 | |
| Walleye Capital LLC |
13F
|
Company |
0.24%
|
199,449
|
$1,876,815 | — | 30 Jun 2025 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.23%
|
189,878
|
$1,786,752 | — | 30 Jun 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.21%
|
172,446
|
$1,622,717 | — | 30 Jun 2025 | |
| David Scott Jones |
3/4/5
|
SVP & Chief Commercial Officer |
—
mixed-class rows
|
54,291
mixed-class rows
|
$1,437,581 | — | 09 Feb 2024 | |
| Dario A. Paggiarino |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
68,106
mixed-class rows
|
$1,386,544 | — | 30 Mar 2024 | |
| XTX Topco Ltd |
13F
|
Company |
0.17%
|
137,950
|
$1,298,110 | — | 30 Jun 2025 |
Institutional Holders of EyePoint, Inc. - Common Stock (EYPT) as of Q3 2025
As of 30 Sep 2025,
EyePoint, Inc. - Common Stock (EYPT) was held by
148 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,898,687 shares.
The largest 10 holders included
Cormorant Asset Management, LP, SUVRETTA CAPITAL MANAGEMENT, LLC, ADAGE CAPITAL PARTNERS GP, L.L.C., BlackRock, Inc., FEDERATED HERMES, INC., FRANKLIN RESOURCES INC, VANGUARD GROUP INC, TCG Crossover Management, LLC, CITADEL ADVISORS LLC, and Paradigm Biocapital Advisors LP.
This page lists
148
institutional shareholders reporting positions in this security
for the Q3 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
139
Q3 2025 holders
148
Holder diff
9
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 Value $ | Q3 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.